1 |
Prathapan P. Magic bullets, magic shields, and antimicrobials in between. Pharmaceutical Science Advances 2022. [DOI: 10.1016/j.pscia.2022.100002] [Reference Citation Analysis]
|
2 |
Li YQ, Zheng Z, Liu QX, Lu X, Zhou D, Zhang J, Zheng H, Dai JG. Repositioning of Antiparasitic Drugs for Tumor Treatment. Front Oncol 2021;11:670804. [PMID: 33996598 DOI: 10.3389/fonc.2021.670804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
3 |
Li XQ, Yue CW, Xu WH, Lü YH, Huang YJ, Tian P, Liu T. A milbemycin compound isolated from Streptomyces Sp. FJS31-2 with cytotoxicity and reversal of cisplatin resistance activity in A549/DDP cells. Biomed Pharmacother 2020;128:110322. [PMID: 32505822 DOI: 10.1016/j.biopha.2020.110322] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Li X, Wan L, Wang F, Pei H, Zheng L, Wu W, Ye H, Wang Y, Chen L. Barbigerone reverses multidrug resistance in breast MCF-7/ADR cells. Phytother Res 2018;32:733-40. [PMID: 29368443 DOI: 10.1002/ptr.6026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
5 |
Heckler R, Almeida G, Santos L, Borges D, Neves J, Onizuka M, Borges F. P-gp modulating drugs greatly potentiate the in vitro effect of ivermectin against resistant larvae of Haemonchus placei. Veterinary Parasitology 2014;205:638-45. [DOI: 10.1016/j.vetpar.2014.08.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
|
6 |
Wang PP, Xu DJ, Huang C, Wang WP, Xu WK. Astragaloside Ⅳ reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines. Mol Med Rep 2014;9:2131-7. [PMID: 24676670 DOI: 10.3892/mmr.2014.2074] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
|
7 |
Qin Q, Ma P, Kuang X, Gao M, Mo D, Xia S, Jin N, Xia J, Qi Z, Lin C. Novel function of N,N-bis(2-chloroethyl)docos-13-enamide for reversal of multidrug resistance in tongue cancer. European Journal of Pharmacology 2013;721:208-14. [DOI: 10.1016/j.ejphar.2013.09.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
8 |
Xia CQ, Smith PG. Drug Efflux Transporters and Multidrug Resistance in Acute Leukemia: Therapeutic Impact and Novel Approaches to Mediation. Mol Pharmacol 2012;82:1008-21. [DOI: 10.1124/mol.112.079129] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 6.2] [Reference Citation Analysis]
|
9 |
Prichard R, Ménez C, Lespine A. Moxidectin and the avermectins: Consanguinity but not identity. Int J Parasitol Drugs Drug Resist 2012;2:134-53. [PMID: 24533275 DOI: 10.1016/j.ijpddr.2012.04.001] [Cited by in Crossref: 159] [Cited by in F6Publishing: 148] [Article Influence: 14.5] [Reference Citation Analysis]
|
10 |
Lespine A, Ménez C, Bourguinat C, Prichard RK. P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance. Int J Parasitol Drugs Drug Resist 2012;2:58-75. [PMID: 24533264 DOI: 10.1016/j.ijpddr.2011.10.001] [Cited by in Crossref: 113] [Cited by in F6Publishing: 102] [Article Influence: 9.4] [Reference Citation Analysis]
|